842| 1
|
[研发注册] 临床试验期间增加药品规格,是申报IND还是申请补充申请? |
|手机版|蒲公英|ouryao|蒲公英
( 京ICP备14042168号-1 ) 增值电信业务经营许可证编号:京B2-20243455 互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033
GMT+8, 2025-10-21 00:32
Powered by Discuz! X3.4
Copyright © 2001-2020, Tencent Cloud.